Modern technologies in clinical trials
Pharma is reaching a tipping point where being flexible in clinical trials design is outweighing the need to be risk-averse within a highly regulated environment. This white paper addresses why sponsors no longer have to choose between speed/flexibility and minimizing risk.
Add bookmark
Pharma firms that utilize modern technologies in their clinical trials operations stand to benefit by establishing the foundation to leverage the best new features and innovations in an infrastructure architecture – all without sacrificing security and quality.
This white paper from 4G Clinical aims to demystify the use of modern technology for randomization and trial supply management (RTSM), and explores what the modern technology stack comprises and how it can address the limitations of traditional RTSMs.
It also looks at how quickly evolving technology can affect clinical trials operations, why modern technology such as microservices architecture and Kubernetes offer business advantages, and what a fully cloud-based, modern technology stack can do to address limitation concerns.
Share best practice, ideas, and solutions to our global community of more than 125,000 senior pharmaceutical and biotech professionals. View our latest Media Kit to learn more about our audience and review our content calendar. Download NowInterested in presenting your own Case Study?
Download this report to find out:
- What the modern technology stack means for clinical researchers.
- How modern technology addresses the limitations of traditional RTSMs.
- Why robust security and scalability benefits clinical trial infrastructure.
